Clinical Trial to Evaluate the Effect of a Probiotic Mixture on the Rosacea Evolution
Rosacea, Rosacea Papular Type, Rosacea, Papulopustular
About this trial
This is an interventional treatment trial for Rosacea
Eligibility Criteria
Inclusion Criteria: Patients of both sexes of an age equal to or greater than 18 years. Patients diagnosed with papulopustular rosacea with a minimum score of 2 points according to the Investigator's Global Assessment (IGA) index. Signature of informed consent by the patient Exclusion Criteria: Pregnant, lactating, and/or women who do not agree to use an effective contraceptive method during the development of the study. Allergy and/or intolerance to any of the components of the product under study. Consumption of antibiotics in the previous two weeks. Consumption of probiotics in the previous two months. Isotretinoin use in the previous six months. Light procedures (IPL, laser, Kleresca) in the previous three months. Participation in other clinical studies in the previous two months. Other dermatological pathologies.
Sites / Locations
- Gavín Dermatologists ClinicRecruiting
- Eguren Dermatology and Aesthetics ClinicRecruiting
- MiBioPath UCAM Research GroupRecruiting
- Salamanca University Hospital. Dermatology Service
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Probiotic group
Placebo group
Probiotic mixture in oral capsule format with selected strains in concentrations equal to or greater than 1x10^10 cfu/dose.
Maltodextrin in oral capsule format